- Home
- CCIF vs PAVM Comparison
CCIF vs PAVM Comparison
Compare CCIF & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CCIF | PAVM |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.7M | 41.1M |
| IPO Year | 2011 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CCIF | PAVM |
|---|---|---|
| Price | $2.32 | $2.80 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.50 |
| AVG Volume (30 Days) | ★ 137.2K | 25.0K |
| Earning Date | 01-01-0001 | 11-12-2026 |
| Dividend Yield | ★ 25.90% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,000,000.00 |
| Revenue This Year | N/A | $132.39 |
| Revenue Next Year | N/A | $263.64 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.00 |
| 52 Week Low | $2.20 | $0.21 |
| 52 Week High | $5.49 | $28.44 |
Technical Indicators
Market Signals| Indicator | CCIF | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 38.01 | 30.04 |
| Support Level | $2.20 | $0.21 |
| Resistance Level | $2.48 | $6.56 |
| Average True Range (ATR) | 0.11 | 0.33 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 43.42 | 12.00 |
Price Performance
Historical ComparisonAbout CCIF Carlyle Credit Income Fund Shares of Beneficial Interest
Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing predominantly in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting mainly of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.